BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Rucaparib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rucaparib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

niraparib
12 shared targets
pj34
10 shared targets
veliparib
9 shared targets
olaparib
11 shared targets
atamparib
8 shared targets
talazoparib
7 shared targets
pamiparib
7 shared targets
2x
4 shared targets
leucettamine
3 shared targets
flavone
3 shared targets
Loading evidence profile...

This evidence profile for Rucaparib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.